Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery A Miranda, M Millán, I Caraballo International journal of pharmaceutics 311 (1-2), 75-81, 2006 | 91 | 2006 |
Relationship between drug percolation threshold and particle size in matrix tablets I Caraballo, M Millan, AM Rabasco Pharmaceutical research 13 (3), 387-390, 1996 | 87 | 1996 |
The role of the drug/excipient particle size ratio in the percolation model for tablets M Millán, I Caraballo, AM Rabasco Pharmaceutical research 15 (2), 216-220, 1998 | 73 | 1998 |
Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets I Fuertes, A Miranda, M Millán, I Caraballo European journal of pharmaceutics and biopharmaceutics 64 (3), 336-342, 2006 | 64 | 2006 |
Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets A Miranda, M Millán, I Caraballo Journal of pharmaceutical sciences 96 (10), 2746-2756, 2007 | 62 | 2007 |
Percolation thresholds in ultrasound compacted tablets I Caraballo, M Millán, A Fini, L Rodriguez, C Cavallari Journal of controlled release 69 (3), 345-355, 2000 | 45 | 2000 |
Study of critical points of drugs with different solubilities in hydrophilic matrices I Fuertes, I Caraballo, A Miranda, M Millán International journal of pharmaceutics 383 (1-2), 138-146, 2010 | 40 | 2010 |
Study of percolation thresholds in ternary tablets I Caraballo, M Fernandez-Arevalo, M Millán, AM Rabasco, ... International journal of pharmaceutics 139 (1-2), 177-186, 1996 | 33 | 1996 |
Study of the critical points in lobenzarit disodium hydrophilic matrices for controlled drug delivery A Miranda, M MillÁn, I Caraballo Chemical and pharmaceutical bulletin 54 (5), 598-602, 2006 | 26 | 2006 |
Study of morphine hydrochloride percolation threshold in Eudragit® RS–PM matrices LM Melgoza, I Caraballo, J Alvarez-Fuentes, M Millán, AM Rabasco International journal of pharmaceutics 170 (2), 169-177, 1998 | 25 | 1998 |
Zero-order release periods in inert matrices. Influence of the distance to the percolation threshold I Caraballo, M Millán, AM Rabasco, H Leuenberger Pharmaceutica Acta Helvetiae 71 (5), 335-339, 1996 | 25 | 1996 |
Validation study of the conductometrical analysis. Application to the drug release studies from controlled release systems. I Caraballo, J Alvarez-Fuentes, LM Melgoza, M Millán, MA Holgado, ... Journal of pharmaceutical and biomedical analysis 18 (1-2), 281, 1998 | 23 | 1998 |
Influence of two different types of excipient on drug percolation threshold MC Soriano, I Caraballo, M Millan, RT Pinero, LM Melgoza, AM Rabasco International journal of pharmaceutics 174 (1-2), 63-69, 1998 | 18 | 1998 |
Superdisintegrants in tablet formulations I Caraballo, M Fernandez-Arevalo, M Millan Drug Dev Ind Pharm 23, 665-669, 1997 | 18 | 1997 |
Stability study of flutamide in solid state and in aqueous solution A Miranda, I Caraballo, M Millan Drug development and industrial pharmacy 28 (4), 413-422, 2002 | 16 | 2002 |
Effect of drug particle size in ultrasound compacted tablets: continuum percolation model approach M Millán, I Caraballo International journal of pharmaceutics 310 (1-2), 168-174, 2006 | 13 | 2006 |
Application of a new mathematical method for the estimation of the mean surface area to calculate the percolation threshold of lobenzarit dissodium salt in controlled release … A Boza, R Blanquero, M Millan, I Caraballo Chemical and pharmaceutical bulletin 52 (7), 797-801, 2004 | 9 | 2004 |
Application of percolation theory to characterize the release behavior of carteolol matrix systems I Caraballo, MA Holgado, M Fernández-Arévalo, M Millán, AM Rabasco Drug development and industrial pharmacy 23 (1), 1-8, 1997 | 8 | 1997 |
Study of the critical points in the release and hydration kinetics of swellable matrix type controlled delivery systems A Miranda, M Millán, I Caraballo Int J Pharm 311 (1), 75-81, 2006 | 7 | 2006 |
Optimisation of a complexation process as a new method for obtaining a controlled morphine delivery system M Fernández-Arévalo, I Caraballo, M Millán, MA Holgado, ... STP pharma sciences 12 (5), 334-336, 2002 | 6 | 2002 |